Article
The joint role of the immune microenvironment and N7-methylguanosine for prognosis prediction and targeted therapy in acute myeloid leukemia
13 Jun 2025
Abstract excerpt
Background The tumor immune microenvironment (TIME) and N 7 -methylguanosine (m7G) modification play crucial roles in the progression of acute myeloid leukemia (AML). This study aims to establish an IME-related and m7G-related prognostic model for improved risk stratification and personalized treatment in AML. Methods Immune score for the Cancer Genome Atlas acute myeloid leukemia (AML) patients were calculated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
